Novoray (SHSE:688300) Marketable Securities: ¥825 Mil (As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Novoray Corp SHSE:688300

80 GF Score

Price ¥139.14

GF Value ¥67.33

Valuation Significantly Overvalued

2 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Novoray Marketable Securities?

Novoray SHSE:688300 -4.25% 80 Marketable Securities is ¥825 Mil as of Jun. 2026. GuruFocus rates SHSE:688300 with a GF Score™ of 80/100 and a GF Value™ of ¥67.33 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Novoray's Marketable Securities for the quarter that ended in Jun. 2026 was ¥825 Mil.

Novoray's annual Marketable Securities declined from Dec. 2023 (¥276 Mil) to Dec. 2024 (¥215 Mil) but then increased from Dec. 2024 (¥215 Mil) to Dec. 2025 (¥216 Mil).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Novoray (SHSE:688300) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Novoray Marketable Securities Related Terms

Novoray Marketable Securities Historical Data

* Premium members only.

The historical data trend for Novoray's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novoray Marketable Securities Chart

Novoray Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Marketable Securities

Get a 7-Day Free Trial

225.67

304.97

275.66

214.67

215.76

Novoray Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Marketable Securities	Get a 7-Day Free Trial															145.14	215.91	215.76	457.28	825.24

80GF Score

Novoray Corp SHSE:688300

Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Novoray Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →

What does a Marketable Securities of ¥825 Mil mean?

Novoray (SHSE:688300) has a Marketable Securities of ¥825 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Novoray and its competitors.

Is Novoray's Marketable Securities too high?

Novoray's current Marketable Securities is ¥825 Mil. Overall, Novoray has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Novoray's Marketable Securities compare to LIN and SHW?

Novoray's Marketable Securities of ¥825 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Marketable Securities for a Chemicals company?

A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Marketable Securities mean?

A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Novoray and its competitors. Novoray's current Marketable Securities is ¥825 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Novoray stock overvalued right now?

Based on GuruFocus' analysis, Novoray (SHSE:688300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥67.33, compared to a current price of ¥139.14 — trading 106.7% above its estimated fair value. The current Marketable Securities is ¥825 Mil. Novoray's overall GF Score™ is 80/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Marketable Securities calculated?

Marketable Securities is calculated from a company's financial statements. For Novoray (SHSE:688300), the current Marketable Securities is ¥825 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novoray (SHSE:688300) Overvalued in 2026?

Based on GuruFocus' analysis, Novoray stock appears to be overvalued. The current stock price of ¥139.14 is trading 106.7% above its estimated GF Value™ of ¥67.33. GuruFocus considers Novoray to be Significantly Overvalued.

Key valuation signals for SHSE:688300:

Marketable Securities: ¥825 Mil
GF Value™: ¥67.33 vs. price of ¥139.14 (106.7% above fair value)
GF Score™: 80/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →